Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 2 Active not recruiting 2 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

OTHER 24 INDUSTRY 3 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1

Interventions

Cisplatin 15 Paclitaxel 14 Taxes 10 Cyclophosphamide 9 Carboplatin 9 Gemcitabine 7 Platinum 6 1,2-diaminocyclohexaneplatinum II citrate 6 Trastuzumab 5 Radiotherapy 5 Oxaliplatin 5 Doxorubicin 5 Docetaxel 5 Cytarabine 5 Capecitabine 5 Brachytherapy 5 fludarabine 4 Rituximab 4 Radiotherapy, Intensity-Modulated 4 Radiosurgery 4 Fluorouracil 4 Dexamethasone 4 Watchful Waiting 3 Radiotherapy, Conformal 3 Pemetrexed 3 Nimorazole 3 Lenalidomide 3 Imatinib Mesylate 3 Idarubicin 3 Gene Expression Profiling 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NETWORK × venetoclax × Clear all

NCT03505944 2021-10-13

VALERIA

Nordic Lymphoma Group

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡